Yorkville Advisors Global LP Takes Position in Inspira Technologies OXY B.H.N. Ltd. $IINN

Yorkville Advisors Global LP acquired a new stake in shares of Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 1,783,844 shares of the company’s stock, valued at approximately $1,605,000. Inspira Technologies OXY B.H.N. accounts for 1.0% of Yorkville Advisors Global LP’s investment portfolio, making the stock its 13th largest position.

Separately, Citadel Advisors LLC bought a new stake in shares of Inspira Technologies OXY B.H.N. during the third quarter valued at approximately $105,000. 12.72% of the stock is currently owned by hedge funds and other institutional investors.

Inspira Technologies OXY B.H.N. Stock Down 24.7%

Shares of IINN opened at $2.32 on Thursday. Inspira Technologies OXY B.H.N. Ltd. has a 1 year low of $0.34 and a 1 year high of $1.65. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.56 and a quick ratio of 1.30. The stock has a 50 day simple moving average of $0.71 and a 200-day simple moving average of $0.78.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Inspira Technologies OXY B.H.N. in a research report on Friday, April 10th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.

About Inspira Technologies OXY B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.